[APLS] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -62.14%
YoY- -210.53%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 646 0 0 -142 0 0 0 -
PBT -135,700 -118,617 -168,822 -113,217 -69,825 -71,090 -50,574 92.74%
Tax 9,483 6,914 3,933 3,981 540 388 340 814.13%
NP -135,700 -118,617 -168,822 -113,217 -69,825 -71,090 -50,574 92.74%
Tax Rate - - - - - - - -
Total Cost 136,346 118,617 168,822 113,075 69,825 71,090 50,574 93.35%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -21,006.19 0.00 0.00 79,646.45 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -1.79 -1.57 -2.29 -1.54 -1.10 -1.12 -0.87 61.55%
EPS Diluted -1.79 -1.57 -2.29 -1.54 -1.10 -1.12 -0.87 61.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.